Pritesh Shah, Chief Growth Officer at NovoCure Ltd (NVCR), sold 273 shares at $21.82 ($6K) on 2023-09-01, disclosed to the SEC on 2023-09-05.
Seasonal sale ($6k) by Chief Growth Officer — this insider has traded NVCR in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |
| NVCR | SELL | 2023-01-09 | $42K | — | Filing → |